COMMUNIQUÉS West-GlobeNewswire

Aptevo Therapeutics Reports 2018 Financial Results and Provides Business Update
18/03/2019
Achieves Record Annual IXINITY ® Net Revenue of $23.1 Million Representing 111% Increase Over 2017 Advances APVO436 Into Phase 1/1b Clinical Trial for Treatment of Acute Myeloid Leukemia and High-Grade Myelodysplastic [...]
Innovate Biopharmaceuticals Announces Entry Into Securities Purchase Agreement to Fund Initiation of the First Phase 3 Celiac Disease Clinical Trial
18/03/2019
RALEIGH, N.C., March 18, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate” or the “Company”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel autoimmune and [...]
Share buy-back week 11/2019
18/03/2019
Announcement 18 March 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling [...]
UPDATE: Tauriga Sciences, Inc. Receives Initial $54,000 Tauri-Gum Purchase Order from Major New York City Based Distributor
18/03/2019
NEW YORK, NY, March 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
Identification of Phosphodiesterease 3A Polymorphism With Potential to Increase Effectiveness of PDE3 Inhibitors Published in the Journal of the American College of Cardiology
18/03/2019
WESTMINSTER, Colo., March 18, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]
Yield Growth Doubles Down on Hemp Root Oil -- CFN Media
18/03/2019
SEATTLE, March 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Minerva Neurosciences to Host Webcast Event on Schizophrenia
18/03/2019
Decision Resources Group to provide review of the disease landscape and forecast Key opinion leader to discuss negative symptoms in schizophrenia Minerva to outline roluperidone’s potential position within the disease [...]
Pascal Biosciences Partners with Mitacs to Support Innovative Cancer Research at University of British Columbia
18/03/2019
VANCOUVER, British Columbia and SEATTLE, March 18, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced a partnership with [...]
North America’s Fastest Growing Cannabis Retailers
18/03/2019
VANCOUVER, British Columbia, March 18, 2019 (GLOBE NEWSWIRE) -- According to a recent Forbes article , North America is expected to become the single largest legal cannabis market in the world, growing to approximately [...]
MedTainer Adopted by 12 LPs; US Market Next in Line
18/03/2019
CORONA, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- MedTainer Inc. (MDTR-OTCMARKETS) announced today that 3 more Canadian Licensed Producers have adopted the MedTainer™ , bringing the number of LPs using MedTainers as [...]
Daré Bioscience, Inc. to Present at the 31st Annual ROTH Conference
18/03/2019
SAN DIEGO, March 18, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Johnson, President and Chief Executive Officer, will present at the [...]
Corcept Therapeutics Appoints Former Amgen Development Executive, Andreas Grauer, M.D., as Chief Medical Officer
18/03/2019
MENLO PARK, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic [...]
Pulse8 extends the Utility and Technology of its powerful analytic engine, Illumin8 Active Intelligence™ platform
18/03/2019
NASHVILLE, March 18, 2019 (GLOBE NEWSWIRE) -- Pulse8, part of Veradigm™, an Allscripts (NASDAQ: MDRX) business unit, the first – and ONLY one with a patent pending – healthcare analytics and technology company [...]
Blissco Signs Supply Agreement with Alberta Gaming, Liquor and Cannabis (AGLC)
18/03/2019
Not for distribution in the U.S. or to U.S. Newswires VANCOUVER, British Columbia, March 18, 2019 (GLOBE NEWSWIRE) -- Blissco Cannabis Corp. ( CSE: BLIS ) ( OTCQB: HSTRF ) ( FRA: GQ4B ), (“Blissco”) or the (“Company”) [...]
CMR Surgical strengthens Board of Directors
18/03/2019
CMR Surgical Limited ("CMR Surgical" or the "Company") CMR Surgical strengthens Board of Directors Cambridge, UK, 18 March 2019 : CMR Surgical Ltd, the British company developing a next-generation surgical robot, today [...]
Daré Bioscience Announces Publication of Positive Clinical Findings for Vaginal Administration of Tamoxifen for the Treatment of VVA
18/03/2019
DARE-VVA1 is a proprietary formulation of tamoxifen for vaginal administration as a potential treatment for VVA in patients with hormone-receptor-positive breast cancer SAN DIEGO, March 18, 2019 (GLOBE NEWSWIRE) -- Daré [...]
VBI Vaccines to Present at the Oppenheimer 29th Annual Healthcare Conference
18/03/2019
CAMBRIDGE, Mass., March 18, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, [...]
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Operational Highlights
18/03/2019
Phase 3 RECOVERY Trial of Tonmya® for the Treatment of PTSD Initiated and Enrolling Topline Data Expected First Half 2020 NEW YORK, March 18, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) ( [...]
Mapi Pharma Receives Government of Israel Funding for the Establishment of a Finished Dosage Form Facility for the Manufacturing of GA Depot Pharmaceuticals
18/03/2019
Plant will enable Mapi to supply the initial commercial needs of GA Depot NESS ZIONA, Israel, March 18, 2019 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, clinical, late stage biopharmaceutical company, [...]

Pages